Close
AI in Healthcare & Pharma Summit Boston 2026

Novo, Nanexa Ink EUR 1.165B Injectible Technology Agreement

Novo has entered into a global exclusive license agreement with Swedish biotech company Nanexa to gain access to its longer-lasting drug delivery technology. The...

FAYUVI Wins FDA Approval to Treat Sanfilippo Syndrome Type A

Ultragenyx Pharmaceutical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted standard full approval to FAYUVI (rebisufligene etisparvovec-hopf), also known as...

interpack China 2026 Preview: Tackling Packaging Challenges with Actionable Solutions

In today’s rapidly evolving market, packaging companies face an increasingly complex set of challenges. Fluctuating raw material prices and supply chains, the ongoing balancing...

Eli Lilly Announces Acquisition of Merida Biosciences

Eli Lilly has entered into a definitive agreement to acquire Merida Biosciences. This USD 2.875B deal aims to expand the developer's immunology portfolio by...

Hanmi Science, Megazone to Advance Pharma AI Transformation

South Korea's Hanmi Science, the holding company of Hanmi Group, has entered into a partnership with Megazone to advance AI transformation (AX) across the...

Lundbeck, EVERSANA to Scale AI-Powered Commercialization

Lundbeck, a global biopharmaceutical organization dedicated exclusively to brain health advancement, has announced an expanded strategic partnership with EVERSANA, a leading independent provider of...

Lonza Launches Custom Cell Culture Media Prototyping Service

Lonza has launched a rapid custom media prototyping service aimed at helping life sciences customers accelerate the early-stage development of cell culture media formulations....

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...